| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, CFO &Cbo | CFO &Cbo
1 company
Savitz Ryan is an EVP, CFO &Cbo at Dianthus Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | DNTH Dianthus Therapeutics, Inc. | EVP, CFO &Cbo | Sale+OE | 114,367 | $83.00 | $9,492,595.50 | -18.5% | - | - | |
| Dec 4, 2025 | DNTH Dianthus Therapeutics, Inc. /de/ | CFO &Cbo | Sale+OE | 20,000 | $45.18 | $903,600.00 | -100% | +38.7% | - | |
| Sep 9, 2025 | DNTH Dianthus Therapeutics, Inc. /de/ | CFO &Cbo | Sale+OE | 20,000 | $35.00 | $700,000.00 | -100% | +22.6% | - |